ALXN: Alexion Pharmaceuticals, Inc. Shares Yearly Stock Returns

Year	Beginning Price	Ending Price	Gain or Loss	Percent Gain or Loss
1997	8.6875	12.50	3.8125	43.88%
1998	12.50	13.375	0.875	7.00%
1999	13.375	30.125	16.75	125.23%
2000	30.125	64.9375	34.8125	115.56%
2001	64.9375	24.44	-40.4975	-62.36%
2002	24.44	14.12	-10.32	-42.23%
2003	14.12	17.01	2.89	20.47%
2004	17.01	25.20	8.19	48.15%
2005	25.20	20.25	-4.95	-19.64%
2006	20.25	40.39	20.14	99.46%
2007	40.39	75.03	34.64	85.76%
2008	75.03	72.38*	-2.65	-3.53%
2009	36.19	48.82	12.63	34.90%
2010	48.82	80.55	31.73	64.99%
2011	80.55	71.50	-9.05	-11.24%
2012	71.50	93.74	22.24	31.10%
2013	93.74	132.884	39.144	41.76%
2014	132.884	185.03	52.146	39.24%
2015	185.03	190.75	5.72	3.09%
2016	190.75	122.35	-68.40	-35.86%
2017	122.35	119.59	-2.76	-2.26%
2018	119.59	97.36	-22.23	-18.59%
2019	97.36	108.15	10.79	11.08%
2020	108.15	156.24	48.09	44.47%
2021	156.24	183.740475*	27.500475	17.60%

*The 2008 ending price for Alexion Pharmaceuticals has been adjusted for a 2 for 1 stock split.
*In 2021, Alexion Pharmaceuticals (ALXN) was acquired by AstraZeneca (AZN). ALXN shareholders received $60 in cash and 2.1243 shares of AZN for every share of ALXN held.

Calculations do not reflect any dividends paid or any stock spinoffs from original stock. Taxes and commissions are not factored into calculations. Data is property of 1stock1 and written permission must be granted before redistributing any data (in part or in whole).